TRAVERE THERAPEUTICS INC

Ticker: TVTX CUSIP: 89422G107 Class: Common Stock

Finepoint Capital LP's Holding History (CIK: 0001608126)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 1,782,267 Value ($000) $24,934 Avg Close $10.42 Range $7.72 - $15.36
Q2 2024
Shares 1,776,728 Value ($000) $14,605 Avg Close $6.73 Range $5.12 - $8.38
Q1 2024
Shares 1,649,221 Value ($000) $12,715 Avg Close $8.44 Range $7.11 - $10.27
Q4 2023
Shares 1,435,321 Value ($000) $12,904 Avg Close $7.28 Range $5.25 - $9.70
Q3 2023
Shares 895,821 Value ($000) $8,009 Avg Close $14.11 Range $7.00 - $17.57
Q2 2023
Shares 761,721 Value ($000) $11,700 Avg Close $18.19 Range $14.51 - $23.18
Q1 2023
Shares 875,221 Value ($000) $19,684 Avg Close $21.26 Range $17.82 - $23.18
Q4 2022
Shares 1,026,300 Value ($000) $22 Avg Close $21.19 Range $17.97 - $26.55
Q3 2022
Shares 1,028,875 Value ($000) $25,351 Avg Close $25.84 Range $22.00 - $29.14
Q2 2022
Shares 584,300 Value ($000) $14,158 Avg Close $25.15 Range $20.80 - $30.35